

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30568951 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.79483218 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.68039695 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.68039695 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.68039695 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.68039695 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.68039695 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.68039695 |
| 9 | response to peptidoglycan (GO:0032494) | 4.53877519 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.41835830 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.20276698 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 4.18712913 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.16297058 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.08807685 |
| 15 | cellular extravasation (GO:0045123) | 3.95528105 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91715027 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84305624 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.82166879 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.82166879 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.78858263 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.68941287 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.67879922 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.65868009 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65604464 |
| 25 | T cell migration (GO:0072678) | 3.63145705 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.62341016 |
| 27 | detection of other organism (GO:0098543) | 3.58124153 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.56421737 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.56307220 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.50762586 |
| 31 | type I interferon signaling pathway (GO:0060337) | 3.49171041 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.49171041 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.48493795 |
| 34 | response to type I interferon (GO:0034340) | 3.45573393 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.39508914 |
| 36 | defense response to protozoan (GO:0042832) | 3.37825785 |
| 37 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.36946304 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.36090833 |
| 39 | B cell mediated immunity (GO:0019724) | 3.32321136 |
| 40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30133927 |
| 41 | response to protozoan (GO:0001562) | 3.29067069 |
| 42 | microglial cell activation (GO:0001774) | 3.28422588 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27438539 |
| 44 | response to host immune response (GO:0052572) | 3.27438539 |
| 45 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.22649537 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.22604852 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.21289964 |
| 48 | germinal center formation (GO:0002467) | 3.19029168 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.18516653 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.17710120 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15098827 |
| 52 | macrophage activation (GO:0042116) | 3.14879299 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11342992 |
| 54 | positive regulation of interferon-beta production (GO:0032728) | 3.11210925 |
| 55 | detection of bacterium (GO:0016045) | 3.11141241 |
| 56 | myeloid dendritic cell activation (GO:0001773) | 3.10810986 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.10687916 |
| 58 | regulation of interleukin-12 production (GO:0032655) | 3.07704358 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.05762546 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05271940 |
| 61 | granulocyte activation (GO:0036230) | 3.05115285 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.04952742 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01451648 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.98944146 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98662724 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 2.96805705 |
| 67 | neutrophil mediated immunity (GO:0002446) | 2.96661559 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93901625 |
| 69 | neutrophil activation (GO:0042119) | 2.93451596 |
| 70 | response to host (GO:0075136) | 2.90774869 |
| 71 | response to host defenses (GO:0052200) | 2.90774869 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90774869 |
| 73 | respiratory burst (GO:0045730) | 2.89823918 |
| 74 | response to interleukin-15 (GO:0070672) | 2.88456282 |
| 75 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88212437 |
| 76 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87996595 |
| 77 | positive regulation of interleukin-2 production (GO:0032743) | 2.87700204 |
| 78 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87370082 |
| 79 | tolerance induction (GO:0002507) | 2.86508246 |
| 80 | positive regulation of type 2 immune response (GO:0002830) | 2.86229294 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85179660 |
| 82 | positive regulation of interleukin-10 production (GO:0032733) | 2.83886789 |
| 83 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.83589881 |
| 84 | interferon-gamma production (GO:0032609) | 2.82161410 |
| 85 | positive regulation of interleukin-12 production (GO:0032735) | 2.80701323 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79840586 |
| 87 | regulation of chronic inflammatory response (GO:0002676) | 2.79833454 |
| 88 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.79626608 |
| 89 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79609997 |
| 90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78554553 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.78058113 |
| 92 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.76547845 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76269730 |
| 94 | myeloid leukocyte activation (GO:0002274) | 2.75624128 |
| 95 | positive regulation of humoral immune response (GO:0002922) | 2.75550509 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 2.72425620 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.72345934 |
| 98 | regulation of T-helper cell differentiation (GO:0045622) | 2.71953011 |
| 99 | regulation of tolerance induction (GO:0002643) | 2.71497763 |
| 100 | cellular response to interleukin-15 (GO:0071350) | 2.69310693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.57195304 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.51208989 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.10667738 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.58460260 |
| 5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00942895 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.64316192 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48495598 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.38648994 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30331405 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.26228336 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21525956 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08737692 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03138667 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95748263 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.67429472 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62784559 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.57016092 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51085614 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50964841 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.47376217 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43489830 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41009634 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.39506351 |
| 24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.08088312 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07531126 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03446277 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01363825 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95568958 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94373266 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82500057 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80776023 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70603426 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69867101 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69067298 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68582837 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66666365 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64686564 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.64392200 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.59888273 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59736188 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59055950 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58129059 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57802725 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55353234 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53473239 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42700943 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39027949 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36657157 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34474093 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32576156 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.31650559 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29028207 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27816597 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22489968 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22028569 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19494560 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18731357 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18451149 |
| 59 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.15919159 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09821592 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09033550 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06012393 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05161871 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04847154 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03942926 |
| 66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03808560 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98454390 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96997026 |
| 69 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96988658 |
| 70 | * MAF_26560356_Chip-Seq_TH2_Human | 0.90466868 |
| 71 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88946328 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88700844 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84507825 |
| 74 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81462103 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81011726 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80893714 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80059639 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.79490436 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79111818 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79102394 |
| 81 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78576141 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77989276 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.77647657 |
| 84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76936706 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75692849 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75240628 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.73083511 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71645829 |
| 89 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.71536135 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71151457 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70995839 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70079212 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.68721745 |
| 94 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.67309569 |
| 95 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.67309569 |
| 96 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.67309569 |
| 97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67298049 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.67113039 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66472030 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.65623186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.18632477 |
| 2 | MP0003724_increased_susceptibility_to | 3.64452979 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.57340642 |
| 4 | MP0005671_abnormal_response_to | 3.17916946 |
| 5 | MP0003436_decreased_susceptibility_to | 3.14408736 |
| 6 | MP0009785_altered_susceptibility_to | 3.03802440 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.89367688 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.87187525 |
| 9 | MP0001800_abnormal_humoral_immune | 2.80734820 |
| 10 | MP0005387_immune_system_phenotype | 2.71237532 |
| 11 | MP0001790_abnormal_immune_system | 2.71237532 |
| 12 | MP0006082_CNS_inflammation | 2.68265901 |
| 13 | MP0008057_abnormal_DNA_replication | 2.67038332 |
| 14 | MP0000685_abnormal_immune_system | 2.63294896 |
| 15 | MP0002419_abnormal_innate_immunity | 2.61204822 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.52499889 |
| 17 | MP0002723_abnormal_immune_serum | 2.50082950 |
| 18 | MP0005025_abnormal_response_to | 2.46417977 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.25744575 |
| 20 | MP0001819_abnormal_immune_cell | 2.24000548 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.13054089 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.08141316 |
| 23 | MP0002405_respiratory_system_inflammati | 1.97583220 |
| 24 | MP0004947_skin_inflammation | 1.90044862 |
| 25 | MP0009764_decreased_sensitivity_to | 1.88699030 |
| 26 | MP0002398_abnormal_bone_marrow | 1.83326487 |
| 27 | MP0000716_abnormal_immune_system | 1.78547315 |
| 28 | MP0001853_heart_inflammation | 1.78236535 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.78214917 |
| 30 | MP0005310_abnormal_salivary_gland | 1.76021217 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.75105532 |
| 32 | MP0005451_abnormal_body_composition | 1.74242046 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.72014242 |
| 34 | MP0004510_myositis | 1.67113549 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.57050948 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.57036447 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.55127527 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.53088217 |
| 39 | MP0002722_abnormal_immune_system | 1.51618092 |
| 40 | MP0008260_abnormal_autophagy | 1.50299559 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.49375851 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.48915185 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.46137902 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.46137902 |
| 45 | MP0002429_abnormal_blood_cell | 1.43221445 |
| 46 | MP0009278_abnormal_bone_marrow | 1.42578487 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.42358657 |
| 48 | MP0008469_abnormal_protein_level | 1.38803850 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.38313931 |
| 50 | MP0003828_pulmonary_edema | 1.35603623 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.35014280 |
| 52 | MP0008004_abnormal_stomach_pH | 1.31535789 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.30877861 |
| 54 | MP0002006_tumorigenesis | 1.28214516 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.26734288 |
| 56 | MP0003448_altered_tumor_morphology | 1.24609797 |
| 57 | MP0000343_altered_response_to | 1.22871590 |
| 58 | MP0003075_altered_response_to | 1.20436541 |
| 59 | MP0009840_abnormal_foam_cell | 1.19833517 |
| 60 | MP0006054_spinal_hemorrhage | 1.19636940 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.19467521 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.17253291 |
| 63 | MP0000858_altered_metastatic_potential | 1.14635010 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.13833546 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.08010950 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04294869 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.00368152 |
| 68 | MP0002254_reproductive_system_inflammat | 1.00344268 |
| 69 | MP0005166_decreased_susceptibility_to | 0.99010784 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.98662176 |
| 71 | MP0009763_increased_sensitivity_to | 0.96054362 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.95294997 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.92814538 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.92662028 |
| 75 | MP0010307_abnormal_tumor_latency | 0.92014637 |
| 76 | MP0005164_abnormal_response_to | 0.90190601 |
| 77 | MP0004381_abnormal_hair_follicle | 0.87572666 |
| 78 | MP0002396_abnormal_hematopoietic_system | 0.87412747 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.87138826 |
| 80 | MP0000604_amyloidosis | 0.86595297 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.86147310 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 0.85834860 |
| 83 | MP0004883_abnormal_blood_vessel | 0.82781278 |
| 84 | MP0003866_abnormal_defecation | 0.81298584 |
| 85 | MP0001851_eye_inflammation | 0.74634671 |
| 86 | MP0002132_abnormal_respiratory_system | 0.74182205 |
| 87 | MP0001873_stomach_inflammation | 0.73324414 |
| 88 | MP0010094_abnormal_chromosome_stability | 0.72955337 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.71758844 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.70533539 |
| 91 | MP0003091_abnormal_cell_migration | 0.69259483 |
| 92 | MP0000371_diluted_coat_color | 0.68605471 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.67580255 |
| 94 | MP0003690_abnormal_glial_cell | 0.66941928 |
| 95 | MP0005647_abnormal_sex_gland | 0.66930372 |
| 96 | MP0003195_calcinosis | 0.63847099 |
| 97 | MP0002009_preneoplasia | 0.61645482 |
| 98 | MP0000490_abnormal_crypts_of | 0.61541721 |
| 99 | MP0003045_fibrosis | 0.61399520 |
| 100 | MP0000249_abnormal_blood_vessel | 0.58742030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.28888641 |
| 2 | Optic neuritis (HP:0100653) | 5.06850731 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.06850731 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.81853671 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.76279197 |
| 6 | Stomatitis (HP:0010280) | 4.74014144 |
| 7 | Orchitis (HP:0100796) | 4.69833693 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.52883691 |
| 9 | Myositis (HP:0100614) | 4.34736899 |
| 10 | T lymphocytopenia (HP:0005403) | 4.32757295 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.31519449 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.18702103 |
| 13 | Recurrent viral infections (HP:0004429) | 3.87311344 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.81399465 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 3.78356683 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.78082985 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.68843221 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.68843221 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.68843221 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.62410093 |
| 21 | Vasculitis (HP:0002633) | 3.57437132 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56766875 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.46112526 |
| 24 | Recurrent skin infections (HP:0001581) | 3.38375791 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33714444 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31492488 |
| 27 | Meningitis (HP:0001287) | 3.30354557 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.20989575 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12437634 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12437634 |
| 31 | Encephalitis (HP:0002383) | 3.11509705 |
| 32 | Abnormality of T cells (HP:0002843) | 3.06611615 |
| 33 | Increased IgM level (HP:0003496) | 3.01516397 |
| 34 | IgA deficiency (HP:0002720) | 2.98907405 |
| 35 | Leukocytosis (HP:0001974) | 2.96725661 |
| 36 | Hemoptysis (HP:0002105) | 2.94993397 |
| 37 | Eosinophilia (HP:0001880) | 2.92589188 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.92298139 |
| 39 | Arterial thrombosis (HP:0004420) | 2.91989281 |
| 40 | Gangrene (HP:0100758) | 2.91478906 |
| 41 | Disinhibition (HP:0000734) | 2.83565793 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81896943 |
| 43 | Obstructive lung disease (HP:0006536) | 2.81896943 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.72216840 |
| 45 | Urticaria (HP:0001025) | 2.70783165 |
| 46 | IgM deficiency (HP:0002850) | 2.69180913 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.65811680 |
| 48 | Granulocytopenia (HP:0001913) | 2.64487995 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.61872463 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.59235259 |
| 51 | B lymphocytopenia (HP:0010976) | 2.54531491 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.53161708 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.51194797 |
| 54 | IgG deficiency (HP:0004315) | 2.50903699 |
| 55 | Gingivitis (HP:0000230) | 2.50722488 |
| 56 | Hematochezia (HP:0002573) | 2.46932149 |
| 57 | Polyneuropathy (HP:0001271) | 2.44919973 |
| 58 | Anorexia (HP:0002039) | 2.42410875 |
| 59 | Amaurosis fugax (HP:0100576) | 2.42363726 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.41445205 |
| 61 | Colitis (HP:0002583) | 2.40690211 |
| 62 | Chest pain (HP:0100749) | 2.39620071 |
| 63 | Lymphopenia (HP:0001888) | 2.37368746 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.36672248 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.36503968 |
| 66 | Chronic diarrhea (HP:0002028) | 2.36396221 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35631178 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35086480 |
| 69 | Osteomyelitis (HP:0002754) | 2.34848515 |
| 70 | Loss of speech (HP:0002371) | 2.33135327 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.27508785 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.24282067 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.23729834 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.20498585 |
| 75 | Pulmonary embolism (HP:0002204) | 2.20092930 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.19466184 |
| 77 | Cellulitis (HP:0100658) | 2.15570080 |
| 78 | Agnosia (HP:0010524) | 2.09015059 |
| 79 | Fatigue (HP:0012378) | 2.05595563 |
| 80 | Acute hepatic failure (HP:0006554) | 2.04639719 |
| 81 | Viral hepatitis (HP:0006562) | 2.04340413 |
| 82 | Joint swelling (HP:0001386) | 2.03149053 |
| 83 | Myocardial infarction (HP:0001658) | 2.02122544 |
| 84 | Lymphoma (HP:0002665) | 2.00614181 |
| 85 | Recurrent sinusitis (HP:0011108) | 1.99461669 |
| 86 | Keratitis (HP:0000491) | 1.95875355 |
| 87 | Increased IgE level (HP:0003212) | 1.94733630 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 1.94674795 |
| 89 | Slow saccadic eye movements (HP:0000514) | 1.92696905 |
| 90 | Prostate neoplasm (HP:0100787) | 1.92682453 |
| 91 | Gingival bleeding (HP:0000225) | 1.90736694 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.90167702 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89545896 |
| 94 | Glomerulopathy (HP:0100820) | 1.88612433 |
| 95 | Thyroiditis (HP:0100646) | 1.87765085 |
| 96 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.85450773 |
| 97 | Epistaxis (HP:0000421) | 1.85303177 |
| 98 | Pustule (HP:0200039) | 1.83788897 |
| 99 | Dysostosis multiplex (HP:0000943) | 1.83246617 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.82193200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.68315425 |
| 2 | RIPK4 | 3.65702645 |
| 3 | IRAK4 | 2.95211005 |
| 4 | MAP4K1 | 2.91817326 |
| 5 | BLK | 2.78396042 |
| 6 | IRAK3 | 2.74399338 |
| 7 | TXK | 2.73568157 |
| 8 | IKBKE | 2.69941603 |
| 9 | TYK2 | 2.55416527 |
| 10 | CSK | 2.29617689 |
| 11 | BMPR2 | 2.26736566 |
| 12 | PRPF4B | 2.16448826 |
| 13 | EIF2AK3 | 2.00120740 |
| 14 | IKBKB | 1.99793155 |
| 15 | TBK1 | 1.94216666 |
| 16 | ACVR1B | 1.91045343 |
| 17 | MATK | 1.89192338 |
| 18 | JAK3 | 1.89180422 |
| 19 | FGR | 1.85415102 |
| 20 | MARK3 | 1.82139867 |
| 21 | TAOK3 | 1.81464424 |
| 22 | JAK1 | 1.74440996 |
| 23 | MAP3K13 | 1.71692043 |
| 24 | IRAK1 | 1.71560755 |
| 25 | SYK | 1.58247331 |
| 26 | BTK | 1.53175151 |
| 27 | MAP2K3 | 1.47988434 |
| 28 | GRK7 | 1.47092543 |
| 29 | TEC | 1.45698179 |
| 30 | IRAK2 | 1.45103082 |
| 31 | ZAP70 | 1.41872055 |
| 32 | STK24 | 1.35698984 |
| 33 | LYN | 1.26987081 |
| 34 | JAK2 | 1.25504787 |
| 35 | MST4 | 1.25192865 |
| 36 | HCK | 1.17582615 |
| 37 | CHUK | 1.14548718 |
| 38 | TAOK2 | 1.14451864 |
| 39 | FES | 1.14225154 |
| 40 | PIM1 | 1.08507916 |
| 41 | ITK | 1.06899268 |
| 42 | MAP3K3 | 1.06057230 |
| 43 | KIT | 1.05885054 |
| 44 | STK10 | 1.04836162 |
| 45 | YES1 | 1.01993749 |
| 46 | MAP3K1 | 1.01958877 |
| 47 | BRD4 | 0.98281037 |
| 48 | LCK | 0.97281937 |
| 49 | FGFR3 | 0.94788046 |
| 50 | MAP3K5 | 0.92688220 |
| 51 | SIK3 | 0.89268950 |
| 52 | NEK9 | 0.88472273 |
| 53 | NLK | 0.88403099 |
| 54 | PIK3CG | 0.85988069 |
| 55 | CSF1R | 0.83633300 |
| 56 | FRK | 0.81789765 |
| 57 | TGFBR2 | 0.81444928 |
| 58 | TAOK1 | 0.81240333 |
| 59 | NME2 | 0.78726290 |
| 60 | CAMKK2 | 0.76508699 |
| 61 | MELK | 0.72505617 |
| 62 | CDK12 | 0.70639555 |
| 63 | CDK6 | 0.68428538 |
| 64 | MAP3K2 | 0.68100489 |
| 65 | PRKCQ | 0.67927131 |
| 66 | TRPM7 | 0.61782230 |
| 67 | DYRK3 | 0.61365397 |
| 68 | GRK6 | 0.52036385 |
| 69 | RAF1 | 0.47317818 |
| 70 | STK3 | 0.45810642 |
| 71 | PDK1 | 0.45186776 |
| 72 | MOS | 0.44172647 |
| 73 | CDC42BPA | 0.43905617 |
| 74 | CDK4 | 0.43636171 |
| 75 | PDK2 | 0.43394937 |
| 76 | EGFR | 0.43278467 |
| 77 | CLK1 | 0.42567520 |
| 78 | FGFR4 | 0.41606285 |
| 79 | KSR2 | 0.41168505 |
| 80 | SGK2 | 0.40020627 |
| 81 | EPHA3 | 0.39702069 |
| 82 | NEK6 | 0.37643019 |
| 83 | BRSK2 | 0.37001461 |
| 84 | MAPK11 | 0.36532474 |
| 85 | MKNK2 | 0.36017720 |
| 86 | TRIM28 | 0.35757005 |
| 87 | STK38L | 0.32301233 |
| 88 | MAP3K8 | 0.31826151 |
| 89 | STK4 | 0.30872814 |
| 90 | ADRBK2 | 0.30554540 |
| 91 | MAP3K11 | 0.28766688 |
| 92 | SGK3 | 0.28163282 |
| 93 | EIF2AK2 | 0.26860514 |
| 94 | EPHB1 | 0.26195980 |
| 95 | ALK | 0.25805968 |
| 96 | TAF1 | 0.24953189 |
| 97 | ABL1 | 0.24014082 |
| 98 | MAPKAPK2 | 0.23987290 |
| 99 | ERN1 | 0.23045557 |
| 100 | CCNB1 | 0.23032414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.85632236 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73515451 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72563495 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.69248719 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.69241010 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56652237 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46118306 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.41522236 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.41417843 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.18754467 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18605953 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18257308 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.16417748 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.15482024 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.14904962 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.14022279 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06006442 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03093463 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.00420493 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00181554 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.98519894 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.94507540 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81460442 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76474860 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.75950441 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66967886 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66216165 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65194432 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62664220 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.51421603 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49747835 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49244871 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44821430 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.36252146 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35804141 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33881856 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32660255 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29909896 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.26715656 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20089303 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19160200 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.18242632 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13400250 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.12242262 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11213986 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.11138578 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.09584689 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07227268 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94404512 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94383146 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93114892 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92120263 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90110881 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80491192 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78122688 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75259686 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74280590 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71432501 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70133554 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69172546 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67001075 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65136177 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.63531013 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63403579 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62136221 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61143425 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58747380 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56323145 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55905756 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55757306 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53907537 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52112771 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.49752694 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49230226 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45634658 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45303846 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42765392 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42141247 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40858497 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38932666 |
| 81 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.38408325 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.37379052 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35554649 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.34903072 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32317105 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31188729 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30778016 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30301533 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29884653 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28259231 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.26748632 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24568428 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23444920 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23139684 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22289384 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21866181 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.18533717 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18220510 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.17783615 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.16791176 |

